Pacific Biosciences of California, Inc. Notes Payable, Current
Pacific Biosciences of California, Inc. (PACB) had Notes Payable, Current of $1.80 million as of 2022-12-31, per its 10-K filed 2023-02-28.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Long-Term Debt, Current Maturities
us-gaap:NotesPayableCurrent · last filed 2023-02-28
- 2022-12-31: Notes Payable, Current $1.80M.
- 2021-12-31: Notes Payable, Current $1.60M.
- 2019-12-31: Notes Payable, Current $16.00M; Notes Payable, Current as first filed $15.87M.
- 2019-09-30: Notes Payable, Current $15.55M.
| Period end | Notes Payable, Current | Notes Payable, Current as first filed |
|---|---|---|
| 2022-12-31 | $1.80M 10-K · filed 2023-02-28 | |
| 2021-12-31 | $1.60M 10-K · filed 2022-02-28 | |
| 2019-12-31 | $16.00M 10-K · filed 2021-02-26 | $15.87M 10-K · filed 2020-02-28 |
| 2019-09-30 | $15.55M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $15.23M 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $14.94M 10-Q · filed 2019-05-03 | |
| 2017-09-30 | $2.91M 10-Q · filed 2017-11-02 | |
| 2017-06-30 | $2.64M 10-Q · filed 2017-08-02 | |
| 2017-03-31 | $3.12M 10-Q · filed 2017-05-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |